Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 39, Issue 6, Pages 2889-2905
Publisher
Springer Science and Business Media LLC
Online
2022-04-22
DOI
10.1007/s12325-022-02143-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quality of life and patient preferences among Danish patients with ulcerative colitis – results from a survey study
- (2020) Lise Meinicke Hagelund et al. CURRENT MEDICAL RESEARCH AND OPINION
- Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment
- (2020) Glen S. Hazlewood et al. PLoS One
- A qualitative inquiry into patients’ perspectives on individualized priorities for treatment outcomes in inflammatory bowel diseases
- (2020) Welmoed K. van Deen et al. QUALITY OF LIFE RESEARCH
- PGI39 INFLAMMATORY BOWEL DISEASE PATIENT'S TREATMENT PREFERENCES - USING QUALITATIVE PATIENT SURVEY DATA TO DEVELOP A DISCRETE CHOICE EXPERIMENT
- (2020) S. Schubert et al. VALUE IN HEALTH
- Patient decision‐making in severe inflammatory bowel disease: the need for improved communication of treatment options and preferences
- (2019) C. Lai et al. Colorectal Disease
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease
- (2018) Przemysław Holko et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: results of a prospective cross-sectional willingness-to-pay study
- (2018) James Gregor et al. Patient Preference and Adherence
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies
- (2016) Martin Ho et al. VALUE IN HEALTH
- Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study☆
- (2014) J. Burisch et al. Journal of Crohns & Colitis
- Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort
- (2014) Rebecca Hein et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014
- (2014) J. Preiß et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
- (2013) F. Reed Johnson et al. VALUE IN HEALTH
- A framework for organizing and selecting quantitative approaches for benefit-harm assessment
- (2012) Milo A Puhan et al. BMC Medical Research Methodology
- Zu welchen Themen wünschen Patientinnen und Patienten mit Morbus Crohn oder Colitis ulcerosa mehr Informationen und welche eigene Rolle bevorzugen sie bei medizinischen Behandlungsentscheidungen? Ergebnisse einer Betroffenenbefragung in Deutschland
- (2012) S. Conrad et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys
- (2011) Thomas Wilke et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now